India, July 20 -- Fresenius Medical Care AG (FMS), a kidney care company, announced Monday the launch of TherapyWise, a cloud-based analytics within FDA 510(k) cleared NxView4.0 software for the NxStage System One in the U.S.
TherapyWise is integrated into Fresenius' NxView 4.0 software platform and critical care portfolio, combining digital infrastructure, clinical expertise, and secure data management to support hospital kidney replacement therapy programs.
The software securely transmits data from the NxStage System One with NxView to a cloud-based platform, where it aggregates and analyzes program-level metrics, including delivered versus prescribed dose, treatment time per cartridge, and alarm frequency trends.
According to the comp...